Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies

DSpace/Manakin Repository

Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies

Citable link to this page

 

 
Title: Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies
Author: Bulliard, Yannick; Jolicoeur, Rose; Windman, Maurice; Rue, Sarah M.; Ettenberg, Seth; Knee, Deborah A.; Wilson, Nicholas S.; Dranoff, Glenn; Brogdon, Jennifer L.

Note: Order does not necessarily reflect citation order of authors.

Citation: Bulliard, Yannick, Rose Jolicoeur, Maurice Windman, Sarah M. Rue, Seth Ettenberg, Deborah A. Knee, Nicholas S. Wilson, Glenn Dranoff, and Jennifer L. Brogdon. 2013. “Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies.” The Journal of Experimental Medicine 210 (9): 1685-1693. doi:10.1084/jem.20130573. http://dx.doi.org/10.1084/jem.20130573.
Full Text & Related Files:
Abstract: Fc γ receptor (FcγR) coengagement can facilitate antibody-mediated receptor activation in target cells. In particular, agonistic antibodies that target tumor necrosis factor receptor (TNFR) family members have shown dependence on expression of the inhibitory FcγR, FcγRIIB. It remains unclear if engagement of FcγRIIB also extends to the activities of antibodies targeting immunoregulatory TNFRs expressed by T cells. We have explored the requirement for activating and inhibitory FcγRs for the antitumor effects of antibodies targeting the TNFR glucocorticoid-induced TNFR-related protein (GITR; TNFRSF18; CD357) expressed on activated and regulatory T cells (T reg cells). We found that although FcγRIIB was dispensable for the in vivo efficacy of anti-GITR antibodies, in contrast, activating FcγRs were essential. Surprisingly, the dependence on activating FcγRs extended to an antibody targeting the non-TNFR receptor CTLA-4 (CD152) that acts as a negative regulator of T cell immunity. We define a common mechanism that correlated with tumor efficacy, whereby antibodies that coengaged activating FcγRs expressed by tumor-associated leukocytes facilitated the selective elimination of intratumoral T cell populations, particularly T reg cells. These findings may have broad implications for antibody engineering efforts aimed at enhancing the therapeutic activity of immunomodulatory antibodies.
Published Version: doi:10.1084/jem.20130573
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754864/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879888
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters